Pfizer-BioNTech COVID-19 Vaccine Shows High Efficacy in Adolescents
Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.
Analysis: The Effect of Remote Immunization Screenings on Vaccine Uptake
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
Moderna, Pfizer Vaccines Safe and Effective in Pregnant, Lactating Women
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
AstraZeneca Reports Up-to-Date COVID-19 Vaccine Efficacy Results
The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.
Study Examines Role of Flu Vaccine in COVID-19 Infection Rates, Severity
A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity
Independent Review Board Shares Concerns Over Outdated Data in AstraZeneca COVID-19 Clinical Trial
AstraZeneca responded to the concerns by promising to release the most up-to-date data within 48 hours.
COVID-19 Vaccine Recipients Experiencing Delayed 'Vaccine Arm' Reaction
Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.
AstraZeneca’s COVID-19 Vaccine Data Show 79% Efficacy Against Symptomatic Disease
AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.
CDC Report: Most Individuals Complete 2-Dose COVID-19 Vaccine Series
The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.
Using Health Risk Assessments to Identify Service Opportunities
European Countries Suspend Use of AstraZeneca’s COVID-19 Vaccine
Germany, Spain, Ireland, and France, among other EU countries, have decided to temporarily suspend the AstraZeneca COVID-19 vaccine amid reports of serious cases of blood clots.
CMS Increases Medicare Reimbursement Rate for COVID-19 Vaccines
NCPA lauded the higher reimbursement rate in a statement.
Survey: US Adults Prefer a Pharmacy Over a Mass Event to Receive COVID-19 Vaccines
New survey results released by NCPA suggest that many Americans prefer to receive the COVID-19 vaccine from a local health care provider over a mass vaccination event.
Protecting Pharmacists: The PPE Every COVID-19 Vaccinator Needs Now
Are we doing enough to protect those on the front lines?
CDC Issues First Recommendations For People Fully Vaccinated for COVID-19
The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.
Women Pharmacists Are Leading Successful COVID-19 Vaccination Programs
In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.
Maximize Immunization Encounters to Enhance Patient Experience
Improve Immunization Efficiencies With Automation
Pharmacies can leverage technology for their workflow and system management. Here’s how.
Biden Pledges Enough COVID-19 Vaccines for All US Adults By End of May
President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.
Study: Patients Receiving MS Therapy Achieve Response to Common Vaccines
Preliminary findings suggest patients with multiple sclerosis who are taking cladribine can mount and maintain effective vaccine responses.
FDA Updates Storage, Transportation Guidance for Pfizer-BioNTech COVID-19 Vaccine
The FDA is allowing more flexible storage and transportation conditions for Pfizer-BioNTech’s COVID-19 vaccine.
FDA Grants Emergency Use Authorization to Third COVID-19 Vaccine
The FDA has granted emergency use authorization status for the first single-dose vaccine for COVID-19 in the United States.
FDA Panel Endorses Johnson & Johnson's COVID-19 Vaccine for EUA
On Friday, a panel of advisors to the FDA voted to recommend Johnson & Johnson's COVID-19 vaccine, named Ad26.COV2.S, for emergency approval.
FDA Analysis of Johnson & Johnson COVID-19 Vaccine Confirms Safety, Efficacy
On Friday, an advisory panel will meet to evaluate the vaccine candidate and decide whether to recommend for emergency use authorization.
Regulation and Cost Considerations for Pharmacists Administering COVID-19 Vaccines
In our final interview segment, Lee Rosebush dives into improving vaccine distribution, addressing costs, and maintaining records while vaccinating for COVID-19.
Part 2: Pharmacist Leads COVID-19 Vaccination Clinic
In part 2 of our interview, Kaitlyn Rivard, PharmD, leads an insightful discussion on the practical side of administering COVID-19 vaccines.
Regulation and Compliance Amid COVID-19 Vaccination
In part 2 of our interview, Lee Rosebush offers pharmacist-centered guidance on regulation and compliance amid COVID-19 vaccinations.
Avoid Regulation Issues With This State-By-State COVID-19 Vaccination Guide
Lee Rosebush of BakerHostetler law firm discussed how pharmacies can avoid regulatory and compliance issues amid their COVID-19 vaccination programs.
Webinar to Discuss Legal and Ethical Considerations of COVID-19 Vaccination
The MJH Life Sciences™ COVID-19 Coalition is hosting a live webinar event on the legal and ethical considerations of COVID-19 vaccination.
Biden Administration Buys 100 Million More COVID-19 Vaccine Doses
The US government has purchased 100 million more vaccine doses for COVID-19 to stay ahead of increasing demand.
2 Clarke Drive Cranbury, NJ 08512